Introduction
Anoikis, defined as detachment-induced apoptosis (Frisch and Francis, 1994) , reflects the essential requirement of most normal epithelial and mesenchymal cells for extracellular matrix (ECM)-derived signals of survival (Frisch and Screaton, 2001) . When denied of such signals, for example, upon detachment and continued culture in suspension or in soft agar, such cells rapidly undergo apoptosis. The biology of cancer cells is fundamentally different from that of normal cells. One of the hallmarks of cancer is the ability of cancer cells to survive and proliferate in the absence of ECM-derived signals. The capacity of cancer cells for anchorage-independent growth when suspended in soft agar is well-correlated with their tumorigenic potential (Freedman and Shin, 1974) . The mechanism(s) involved in making cancer cells anoikis-resistant are not fully understood, but in general may comprise the stimulation of alternative (i.e. non-ECM) survival signals and/or the inhibition of apoptotic pathways.
Caveolin-1 is an essential protein constituent of plasma membrane caveolae that regulates caveolaedependent endocytosis (Razani et al., 2002) . However, the cellular localization and functions of caveolin-1 appear to transcend its classic role as a caveolar coat component Liu et al., 2002) . Dynamic changes in its expression clearly implicate caveolin-1 in regulation of cell growth. Caveolin-1 is upregulated upon induction of differentiation in various cell types (Scherer et al., 1994; Galbiati et al., 1998b; Li et al., 2001) . Conversely, caveolin-1 is downregulated upon oncogenic transformation (Koleske et al., 1995; Engelman et al., 1998a) . These changes are likely to have functional consequences. Heterologous expression of caveolin-1 in cancer cells slows their proliferation (Lee et al., 1998; Fiucci et al., 2002) and inhibits their anchorage-independent growth (Engelman et al., 1997; Lee et al., 1998; Fiucci et al., 2002) . Conversely, antisense inhibition of endogenous caveolin-1 expression or its functional antagonism by a dominant-acting caveolin-1 mutant (P132L) results in fibroblast transformation (Galbiati et al., 1998a; Hayashi et al., 2001) . Genetic knockout of caveolin-1 results in hyperplasia of pulmonary endothelial cells and mammary gland epithelial cells (Drab et al., 2001; Razani et al., 2001a) . Furthermore, caveolin-1 gene knockout results in increased sensitivity to oncogenic and carcinogenic stimuli (Capozza et al., 2003; Williams et al., 2003) . The chromosomal location of human caveolin-1 is in a locus (7q31.1/D7S522) that is deleted in several forms of cancer Fra et al., 1999) . Together, these data indicate that caveolin-1 is a growth-inhibitory protein and have led to the suggestion that caveolin-1 may act as a tumor-suppressor protein (Razani et al., 2001b) .
Accumulating evidence show, however, that caveolin-1 expression is elevated in many human cancer cell lines and numerous human tumor specimens (reviewed in Liscovitch et al., 2004) . This raises an intriguing question: What are caveolin-1 function(s) in those cancer cells where it is highly expressed? Recent results indicate that in such cells caveolin-1 may promote cell survival. We have previously shown that stable expression of caveolin-1 in MCF-7 mammary adenocarcinoma cells attenuates proliferation and blocks anchorageindependent growth (Fiucci et al., 2002) . Paradoxically, however, analysis of cell survival after detachment demonstrated that MCF-7/Cav1 cells are completely resistant to anoikis, suggesting that caveolin-1 may promote survival in detached cancer cells. Thus, these cells appear to exhibit simultaneously both the growthinhibitory and the prosurvival faces of caveolin-1. Yet, the molecular mechanism underlying the antianoikis action of caveolin-1 remains obscure. In the present study we show that inhibition of anoikis is accompanied by inhibition of detachment-induced activation of p53. Furthermore, we provide evidence that expression of caveolin-1 in human breast cancer cells enhances matrixindependent cell survival by upregulation of insulin-like growth factor-I (IGF-I) receptor expression and signaling. Finally, we show that detachment results in a dramatic and time-dependent increase of caveolin-1 protein levels. Our data identify mechanisms that are involved in the prosurvival action of caveolin-1 and thus may help explain the complex pattern of its expression in human cancer.
Results

Caveolin-1 inhibits induction of p53 and p21 WAF1/Cip1 upon detachment
In a previous study we have shown that stable expression of caveolin-1 attenuates MCF-7 cell proliferation and abrogates colony formation in soft agar. However, this loss of anchorage-independent growth is paradoxically associated with inhibition of anoikis, since MCF-7/Cav1 cells exhibit increased survival after detachment compared to the parental MCF-7 cells (Fiucci et al., 2002) . As MCF-7 cells express a wildtype p53 gene (Wosikowski et al., 1995) , we hypothesized that caveolin-1 may inhibit anoikis via a p53-dependent pathway. Therefore, we examined the induction of p53 in MCF-7 and MCF-7/Cav1 cells upon detachment and continued culture in dishes coated with polyhydroxyethylmethacrylate (poly-HEMA), in which adherence of cells to the dishes is blocked (Xu et al., 2000) . As expected, detachment of MCF-7 cells resulted in a time-dependent elevation of p53 protein that reached a maximum of 3.5-fold after 2 h of nonadherence and then gradually declined (Figure 1a , top). In Caveolin-1 promotes IGF-I signaling and inhibits anoikis D Ravid et al contrast, detachment had little or no effect on p53 levels in MCF-7/Cav1 cells. To verify the functional status of p53 we examined also the expression of its transcriptional target, the cyclin-dependent kinase inhibitor p21 WAF1/Cip1 . As shown in Figure 1a (bottom), the increase of p53 in MCF-7 cells was associated with a slightly delayed, 2.6-fold induction of p21 WAF1/Cip1 , while there was no significant change in its expression in detached MCF-7/Cav1 cells. The results show that the inhibition of anoikis in MCF-7/Cav1 cells is associated with suppression of detachment-induced upregulation of p53 and of the consequent induction of p21 WAF1/Cip1 . The resistance of MCF-7/Cav1 cells to anoikis and p53 induction could indicate that these cells may also be resistant to other apoptosis-inducing stimuli such as cytotoxic drugs. We therefore examined adriamycininduced activation of p53 and p21 WAF1/Cip1 in MCF-7 and MCF-7/Cav1 cells. In contrast to their differential response after detachment, the induction of p53 in response to adriamycin was similar in MCF-7 and MCF-7/Cav1 cells (Figure 2a, top) , while the p21 WAF1/Cip1 response to adriamycin was only slightly attenuated in MCF-7/Cav1 cells (Figure 2a, bottom) . These data indicate that activation of p53 by a DNA damageinducing drug is largely insensitive to expression of caveolin-1. Therefore, the inhibitory effect of caveolin-1 on induction of p53 is not general but is limited to certain stimuli, including deprivation of matrix-derived survival signals.
The role of p53 in mediating anoikis was examined using MCF-7 cells in which expression of p53 was suppressed by stable transfection with a p53-RNAi vector (MCF-7/pSUPER-p53) (Brummelkamp et al., 2002) . Empty vector control cells (MCF-7/pSUPER) express p53 normally and its levels are markedly elevated upon detachment ( Figure 3a) . As expected, in MCF-7/pSUPER-p53 cells, p53 levels are significantly lower and detachment fails to induce any increase in p53 expression. The expression of p21 WAF1/Cip1 generally mirrors the changes observed with p53. The results show that while p53 and consequently p21 WAF1/Cip1 are induced by detachment of the control cells, their induction in the p53-suppressed cells is blocked, confirming that p21 WAF1/Cip1 induction during anoikis is regulated by p53. We next examined the sensitivity of the p53-suppressed cells to anoikis. We have found that, as expected, the MCF-7/pSUPER control cells are sensitive to anoikis to the same extent as the parental MCF-7 cells (Figure 3b ; cf Fiucci et al., 2002) . Surprisingly, the p53-suppressed MCF-7/pSUPER-p53 cells were found to be as sensitive to anoikis as the p53-expressing cells (Figure 3b ). These data led to the conclusion that, although detachment-induced p53 and anoikis are both inhibited by caveolin-1 expression, anoikis is p53-independent in MCF-7 cells. Caveolin may thus regulate a common upstream step leading to parallel activation of p53 and anoikis. Although the inhibition of p53 activation cannot explain anoikis resistance in MCF-7/Cav1 cells, p53 may be a useful surrogate marker for caveolin-1 actions in cancer cells.
Effect of detachment on apoptosis and survival signaling in MCF-7 and MCF-7/Cav1 cells
The acquisition of full resistance to anoikis in MCF-7/ Cav1 cells suggested that caveolin-1 inhibits p53-independent apoptotic mechanism(s) or promotes matrix-independent survival pathway(s) in these cancer cells. These two possibilities were examined by determining the effect of detachment of MCF-7 and MCF-7/ Cav1 cells on a range of proteins that are related to apoptosis and/or survival signaling. It has been shown that MCF-7 cells do not express caspase-3 due to a functional deletion in the CASP-3 gene (Janicke et al., 1998) . These cells can undergo apoptosis in response to different stimuli via sequential activation of caspase-9, -7 and -6 (Benjamin et al., 1998; Tang et al., 2000) . However, our results show that there is little or no difference in the expression of caspase-8, -9, -7 and -6 between MCF-7 and MCF-7/Cav1 cells ( Figure 4a ). Furthermore, these caspases are not activated and remain in their inactive, uncleaved form during anoikis (data not shown). Thus, in MCF-7 cells, anoikis apparently is independent of caspase-6, -7, -8 and -9. Another possibility was that MCF-7/Cav1 cells exhibit upregulation of an antiapoptotic protein (such as Bcl-2) or downregulation of a proapoptotic protein (such as Bid and c-Myc). While no change was observed in cMyc levels, the changes observed in Bcl-2 and Bid expression in MCF-7/Cav1 cells as compared with MCF-7 cells (i.e. decreased and increased expression, respectively; Figure 4a ) are opposite to those expected based on the anoikis-resistant phenotype of the cells and therefore cannot explain the resistance to anoikis in MCF-7/Cav1 cells. However, these data indicate that the prosurvival action of caveolin-1 is sufficiently strong to overcome the apoptosis-promoting actions of elevated Bid and reduced Bcl-2 expression.
Anoikis can be prevented by activation of survival pathways that in adherent cells are stimulated by integrins and growth-factor receptors (Frisch and Screaton, 2001 ). First, we examined whether receptors from the ErbB gene family are upregulated in MCF-7/ Cav1 cells. No change was found in the expression levels of the EGF-R and ErbB2 in adherent cells or upon detachment of MCF-7/Cav1 cells (data not shown). Similarly, we have found no change in the basal activation state of Erk1/2 in adherent cells (cf Figure 5d ) and no Erk1/2 activation upon detachment (not shown). Next, we examined the expression of Figure 4 Immunoblot analysis of apoptosis-and survival-related proteins in MCF-7 and MCF-7/Cav1 cells during detachment. Cells were detached, maintained in suspension in poly-HEMAcoated dishes and then lysed before or at the indicated time after detachment. (a) Caspases -8, -9, -7, -6, c-Myc, Bid and Bcl-2 were detected by Western blotting using specific antibodies. The experiment was repeated at least twice with similar results and a representative blot is shown. (b) PI3K/Akt pathway proteins were detected by specific antibodies to PI3-kinase-a regulatory subunit (p85), Akt, phospho-Ser-473-Akt, phospho-Thr-308-Akt, and a phospho-(Ser/Thr) Akt-substrate antibody which detects a B340 kDa Akt phospho-substrate (pp340). The experiment was repeated at least three times with similar results and a representative blot is shown Caveolin-1 promotes IGF-I signaling and inhibits anoikis D Ravid et al constituents of the phosphoinositide 3-kinase (PI3K)/ Akt survival pathway during anoikis. While the levels of the p85 (the regulatory subunit of PI3K-a) and the Akt kinase remained unaffected upon detachment, the active phospho-Akt (detected with both phospho-Ser-473 and phospho-Thr-308 antibodies) was found to be constitutively elevated in MCF-7/Cav1 cells (Figure 4b ). Moreover, analysis using a phospho-Ser/Thr Akt-substrate antibody, raised against a semidegenerate phosphopeptide representing the Akt consensus phosphorylation motif (Kane et al., 2002; Zhang et al., 2002) , revealed a high molecular-weight putative Akt substrate (provisionally designated pp340) that was present only in MCF-7/Cav1 cells (Figure 4b ). Thus, a constitutively active Akt kinase and at least one phosphorylated putative high molecular weight Akt substrate may mediate enhanced survival of MCF-7/Cav1 cells after detachment.
IGF-I receptors and signaling in MCF-7 and MCF-7/ Cav1 cells IGF-I and its receptors have been strongly implicated in regulation of growth and survival in cancer cells (Werner and LeRoith, 1996; Baserga et al., 2003) . Specifically, IGF-I was shown to protect anchoragedependent cells from anoikis (Valentinis et al., 1998) , whereas caveolin-1 is a target in insulin and IGF-I receptor signaling (Yamamoto et al., 1998; Cohen et al., 2003a; Podar et al., 2003) . Therefore, we tested the hypothesis that changes in IGF-I receptors and/or signaling mediate the resistance to anoikis induced by Figure 5a , the expression levels of the B205-kDa IGF-I receptor precursor and of the mature IGF-I receptor are markedly higher in MCF-7/Cav1 cells than in MCF-7 cells (6.9-and 2.1-fold, respectively). To assess whether the increased IGF-I receptor expression in MCF-7/Cav1 cells is mediated at the transcriptional level, cells were transiently transfected with 'full-length' and 'proximal' IGF-IR promoter fragments fused to a luciferase reporter gene. As shown in Figure 5b , the promoter activity of both p(À2350/ þ 640)LUC and p(À476/ þ 640)LUC constructs was 8.5-to 9-fold higher in MCF-7/Cav1 cells than in control MCF-7 cells. These data clearly indicate that IGF-I receptor promoter activation is enhanced substantially in caveolin-1-expressing MCF-7 cells. We next examined the activation of Akt in response to IGF-I. Basal Akt phosphorylation was higher in MCF-7/Cav1 cells, whereas IGF-I further elevated phospho-Akt after 10 and 30 min of stimulation ( Figure 5c ). Phosphorylation of the putative Akt substrate pp340, detected with the phospho-Ser/Thr Akt-substrate antibody, was also increased further by IGF-I (Figure 5c ), supporting the possibility that it is indeed a downstream target of Akt. In addition, the activation of another signaling target of IGF-I, Erk1/2 was also potentiated significantly by expression of caveolin-1 (Figure 5d ). These data show that caveolin-1 is capable of facilitating IGF-I signaling to Akt and to Erk1/2 in MCF-7 cells and that pp340 may be a downstream target of IGF-I-activated Akt. The ability of IGF-I to protect MCF-7 cells from anoikis was tested directly by adding IGF-I to cells maintained in poly-HEMA-coated dishes for up to 24 h. As shown in Figure 5e , IGF-I completely prevents the loss of viability induced by denial of matrix-derived survival signals in MCF-7 cells. IGF-I also inhibits detachment-induced activation of p53 in the cells (Figure 5f ). It may therefore be concluded that IGF-I can act as a factor that supports anchorage-independent survival and inhibits p53 activation in MCF-7 cells.
Caveolin-1 protein levels are increased upon detachment
Our data indicate that anoikis is negatively regulated by caveolin-1. It was therefore of interest to examine whether detachment may, in turn, regulate caveolin-1 levels during the anoikis experiment. We have found that detachment induced a time-dependent increase in caveolin-1 levels in MCF-7/Cav1 cells ( Figure 6 ). Since caveolin-1 is not endogenous in these cells but is transcribed from a plasmid, we examined another human cancer cell line that expresses endogenous levels of caveolin-1. Previously, we have shown that expression of caveolin-1 in multidrug-resistant HT-29 colon cancer (HT-29 MDR) cells is higher than in the nonresistant parental cells (Lavie et al., 1998) . Like MCF-7/Cav1 cells, HT-29 MDR cells are anoikis-resistant (D Ravid, unpublished observations). The expression of endogenous caveolin-1 in HT-29 MDR cells was dramatically increased upon detachment ( Figure 6 ). As the expression of caveolin-1 in MCF-7/Cav1 cells is driven by a heterologous viral promoter, the molecular mechanism regulating the increase of caveolin-1 after detachment is not likely to be transcriptional but may be due to stabilization of the protein and/or its mRNA. These data show that the levels of caveolin-1 are elevated in cells after detachment. Together with its ability to inhibit anoikis and stimulate IGF-I/Akt signaling, the upregulation of caveolin-1 by detachment suggest that caveolin-1 plays an important physiological role in regulating anchorage-independent survival in human cancer cells.
Discussion
The aim of the present study was to elucidate the mechanism(s) underlying the seemingly paradoxical action of caveolin-1 in MCF-7 cells, where its heterologous expression suppresses anchorage-independent growth while simultaneously inhibiting anoikis (Fiucci et al., 2002) .
Anoikis is often associated with and depends on detachment-induced activation of p53 (Nikiforov et al., 1996; Grossmann, 2002) . Therefore, caveolin-1 could , is likewise inhibited. This is not a general effect as genotoxic stress-induced activation of p53 is minimally affected. However, the inhibition of p53 induction upon detachment cannot explain the action of caveolin-1 on anoikis because RNAi suppression of p53, which abrogates both p53 activation and p21 induction upon detachment, fails to affect anoikis in MCF-7 cells. Our data thus indicate that anoikis is not dependent on p53 activation in MCF-7 cells. Similarly, anoikis is reported to be p53-independent in Myc/Ras-or E1A/Ras-transformed fibroblasts (McGill et al., 1997 ). Yet, the inhibitory effect of caveolin-1 on p53 activation provides a surrogate marker for caveolin action that may help dissect the pathway(s) it regulates.
These data are compatible with a model wherein the expression of caveolin-1 negatively regulates a detachment-induced signaling event that is upstream of, and activates in parallel, both p53 and anoikis. Consistent with this model are our data, showing that downstream apoptosis-related proteins such as caspases and Bcl homology domain proteins are either unchanged in MCF-7/Cav1 cells or are changed in a direction that cannot explain the anoikis resistance of these cells. In fact, the anoikis-resistant MCF-7/Cav1 cells exhibit elevated levels of proapoptotic Bid and reduced levels of antiapoptotic Bcl-2. This indicates that the effect of caveolin-1 is potent enough to permit cell survival upon detachment while overcoming the strong opposing apoptosis-promoting effects of the Bid and Bcl-2 changes.
The PI3K/Akt pathway is an upstream signaling pathway that regulates both p53 activation and cell survival (Gottlieb et al., 2002; Luo et al., 2003) and it has been implicated as an important regulator of anoikis (Khwaja et al., 1997; Lu et al., 1999; Frisch and Screaton, 2001) . Previous work has shown that expression of caveolin-1 may have either a negative or a positive effect on signaling via the PI3K/Akt pathway (Zundel et al., 2000; Podar et al., 2003) . Examination of the status of components of the PI3K/Akt pathway in adherent and detached cells revealed that the phosphorylated form of Akt is constitutively elevated in MCF-7/Cav1 cells. Evidence that phospho-Akt in MCF-7/Cav1 cells is active in vivo is provided by the fact that an antibody directed against a consensus phospho-peptide substrate of Akt reveals a 340 kDa protein that is constitutively phosphorylated in these cells. We conclude that pp340 is a bona fide Akt substrate because its phosphorylation (detected by interaction with Akt consensus motif antibodies) is further enhanced upon stimulation by IGF-I, known to stimulate PI3K/Akt signaling in MCF-7 cells (Dufourny et al., 1997) . We have determined that pp340 is a cytosolic protein (D Ravid, unpublished obeservations). The results of Scansite program searches (http:// scansite.mit.edu/) predict a number of 340-360 kDa proteins that are putative Akt substrates. However, the identity of pp340 is yet unknown and remains as a major aim of our future research.
How does caveolin-1 expression upregulate PI3K/Akt signaling? Caveolin-1 is a known mediator of insulin and IGF-I signaling (Yamamoto et al., 1998; Cohen et al., 2003a) . In addition, IGF-I is a growth and survival factor that protects many cell types, including MCF-7 cells, from anoikis (Valentinis et al., 1998; Scotlandi et al., 2002 ) (cf Figure 5e) . We report here that expression of caveolin-1 results in upregulation of IGF-I receptors in MCF-7 cells. Furthermore, IGF-I-dependent signaling to Erk1/2 and to Akt is potentiated in MCF-7/Cav1 cells. Both Erk1/2 and Akt are survivalpromoting pathways and both have been implicated in resistance to anoikis (Frisch and Screaton, 2001; Grossmann, 2002) , but only Akt appears to be constitutively activated in MCF-7/Cav1 cells. Together, these data raise the possibility that IGF-I, present in the growth medium and/or released from the cells, stimulates its cognate receptors (elevated in MCF-7/Cav1 cells) to mediate enhanced activation of the Akt survival pathway, thus protecting the cells from anoikis. An open question that remains is how caveolin-1 expression leads to upregulation of IGF-I receptors. The results of transient transfection experiments with IGF-I receptor promoter-reporter plasmids are consistent with an action at the transcriptional level. Caveolin-1 may act also as a chaperone that stabilizes the insulin receptor (Cohen et al., 2003b) . Although there was no change in IGF-I receptors in hypogonadal fat pads of these caveolin-1 knockout mice, it is still possible that caveolin-1 could play a similar chaperone-like role for IGF-I receptors in other tissues, including human cancer cells.
In conclusion, high basal activity of Akt in MCF-7/ Cav1 cells, mediated by upregulation of IGF-I receptors, may play a critical role in antagonizing anoikis. Caveolin-1 may also activate Akt via scaffolding domain interaction with, and inhibition of, two classes of serine/threonine phosphatases, namely PP1 and PP2A, that negatively regulate Akt phosphorylation and activity (Li et al., 2003) . How do these seemingly unrelated mechanisms depend on caveolin-1 expression levels and on its cellular context is currently under active investigation in our laboratories.
A major new finding of the present study is the dramatic increase of caveolin-1 protein levels observed upon detachment in MCF-7/Cav1 and HT29-MDR cells, both of which are anoikis-resistant. This result indicates that caveolin-1 is regulated by adherence and, together with our other results, suggests that its upregulation mediates anchorage-independent survival of the cells. Interestingly, caveolin-1 is similarly elevated in both cell types although in MCF-7/Cav1 cells caveolin-1 expression is driven by a viral promoter. This would suggest that detachment regulates caveolin-1 via a nontranscriptional mechanism, possibly by stabilization of caveolin-1 at either the mRNA or protein levels. However, RT-PCR analysis indicates that caveolin-1 mRNA levels remain unchanged after detachment Caveolin-1 promotes IGF-I signaling and inhibits anoikis D Ravid et al (D Ravid, unpublished observations). It was previously shown that oxidative stress induced by subcytotoxic levels of hydrogen peroxide upregulates endogenous caveolin-1 expression in NIH 3T3 cells (Volonte et al., 2002) . Together these data suggest that caveolin-1 expression is regulated by various stress conditions and support a role for caveolin-1 in promoting cell survival under stress. Our previous (Fiucci et al., 2002) and present data indicate that caveolin-1 acts to promote survival in nonadherent human cancer cells. Likewise, recently published data show that crosslinking of the GPIanchored protein CEACAM6 induces a caveolin-1-dependent cellular resistance to anoikis (Duxbury et al., 2004) . These findings accord well with a number of other studies that focused on the role of caveolin-1 in cancer cells. Antisense suppression of caveolin-1 in androgeninsensitive mouse prostate cancer cells reduces their survival upon androgen deprivation (Nasu et al., 1998) . Intriguingly, caveolin-1 seems to exert its prosurvival actions in this system through an autocrine/paracrine mechanism (Tahir et al., 2001) . Furthermore, heterologous expression of caveolin-1 protects LNCaP human prostate cancer cells from c-Myc-induced apoptosis (Timme et al., 2000) . Recent work demonstrated that the inhibition of apoptosis induced by caveolin-1 expression in prostate cancer cells is mediated by caveolin-1 inhibition of the serine/threonine phosphatases PP1 and PP2A (Li et al., 2003) .
The antiapoptotic/prosurvival actions of caveolin-1 may help explain the fact that many human cancer cell lines and numerous human tumor specimens are caveolin-1-positive. Furthermore, the expression of caveolin-1 is often positively correlated with the tumor cell grade and its progression stage and, in some cases, the expression of caveolin-1 was shown to be an independent predictor of poor disease prognosis (reviewed by Liscovitch et al., 2004) . These facts stand in sharp contrast with the tumor suppressor role proposed for caveolin-1, based on its well-established antiproliferative actions and on its location in chromosome 7q31.1 (Razani et al., 2001b) . Overexpression and genespecific suppression studies leave little doubt that caveolin-1 has antiproliferative actions in normal and some cancer cells. However, this implies that caveolin-1 must have another function in those cancer cells where its expression is maintained or even upregulated. Our data suggest that in such cells caveolin-1 promotes cell survival. The ability of caveolin-1 to effect both growthinhibitory and survival-promoting actions may explain its divergent expression in human cancers. We hypothesized that, at early stages of cancer progression (when rapid proliferation is essential for clonal expansion) expression of caveolin-1 is down-regulated, hence suppressing its growth inhibitory actions; conversely, at late, advanced stages of the disease in which metastatic and drug-resistant phenotypes become prevalent (and when survival and stress resistance are vital), expression of caveolin-1 is upregulated, enabling its prosurvival and antiapoptotic actions (Liscovitch et al., 2004) . Additional studies are required in order to elucidate the roles played by caveolin-1 in human cancer cells and to examine the hypothesis that its expression in advanced stage, metastatic and/or multidrug resistant cancer is related to its prosurvival actions.
Materials and methods
Materials
Unless otherwise stated, all reagents were from Sigma (St Louis, MO, USA). Protein assays were performed using a modified Lowry procedure with a commercially available kit (Bio-Rad, Hercules, CA, USA). Antibodies to phospho-Ser-473-Akt, phospho-Thr-308-Akt, phospho-(Ser/Thr)-Akt-substrate, caspase-7 and -8 were from Cell Signaling Technologies (Boston, MA, USA). Antibodies to Bcl-2, c-Myc, actin, IGF-I-R b subunit and p21 WAF1/Cip1 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibody to caspase-9 was from Upstate Biotechnology (Charlottesville, VA, USA). AntiBid and anti-p53 (DC-I/1804) antibodies were kindly provided respectively by Dr Atan Gross and Professor Moshe Oren (Weizmann Institute, Rehovot, Israel). Anti-p85 antibodies were kindly provided by Dr Orna Halevy (Hebrew University, Rehovot, Israel).
Culture of MCF-7 and MCF-7-derived cell lines
Human breast adenocarcinoma MCF-7 cells were kindly provided by Dr Merrill E Goldsmith (National Cancer Institute, Bethesda, MD, USA). MCF-7 cells were grown according to published procedures (Fairchild et al., 1987) . In brief, MCF-7 cells were cultured in monolayer at 371C in a humidified atmosphere containing 5% CO 2 in RPMI medium supplemented with 10% (v/v) heat-inactivated fetal calf serum, penicillin and streptomycin (1000 U/ml each) and glutamine (20 mM) (all from Biological Industries, Beth Haemek, Israel). The generation of caveolin-1-transfected MCF-7/Cav1 cells was described previously (Fiucci et al., 2002) . MCF-7/Cav1 cells were routinely maintained in medium containing 400 mg/ ml G418 (GIBCO-Invitrogen, Carlsbad, CA, USA) but were transferred to drug-free medium for experiments. MCF-7/ pSUPER and MCF-7/pSUPER-p53 were generously provided by Dr Reuven Agami (Netherlands Cancer Institute, Amsterdam, The Netherlands) and stocks were maintained in medium containing 1 mg/ml puromycin.
Cell detachment and suspension culture
To prevent cell adhesion, plastic bacteriological Petri dishes were coated with poly-HEMA, according to a previously published procedure (Xu et al., 2000) . Briefly, a 12% solution of poly-HEMA in 95% ethanol was mixed overnight, clarified by centrifugation at 2500 r.p.m. and diluted 1 : 10 in 95% ethanol. Dishes were coated with the diluted poly-HEMA solution (4 ml per 100-mm dish) and the ethanol solvent was left to evaporate overnight in a laminar flow hood at room temperature. Routinely, cells were detached using trypsin-EDTA, seeded at a concentration of 3 Â 10 6 cells/100-mm dish and cultured in RPMI medium supplemented with 5% (v/v) fetal calf serum for 0-24 h. In experiments with IGF-I, the cells were cultured in serum-free medium supplemented with 0.1% fatty acid-free BSA and 50 ng/ml IGF-I (CytoLab, Rehovot, Israel). At the end of the indicated culture period the cells were collected, precipitated by centrifugation, treated with trypsin-EDTA and resuspended in RPMI medium. Aliquots of 150 ml were transferred to 96-well plates for cell survival assays and
Caveolin-1 promotes IGF-I signaling and inhibits anoikis D Ravid et al the rest of the cells were lysed in RIPA lysis buffer (20 mM Tris, pH 7.4, 137 mM NaCl, 10% glycerol, 0.1% SDS, 0.5% deoxycholate, 1% Triton X-100, 2 mM EDTA pH 8.0, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 2 mM Na 3 VO 4 ) and subjected to immunoblot analysis.
Anoikis assay
Cell survival was determined by using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay as modified by (Hansen et al., 1989) . The MTT assay measures the reduction of the yellow tetrazolium salt into insoluble purple formazan product by mitochondria of viable cells. Briefly, the MTT reagent (diluted from a 5 mg/ml solution in PBS) was added to all the wells at a final concentration of 0.6 mg/ml and the cells were further incubated for 2 or 3 h at 371C. The reaction was terminated and purple formazan was solubilized by adding 100 ml/well of an extraction solution consisting of 20% (w/v) sodium dodecyl sulfate (SDS) in 50% aqueous dimethyl formamide solution, pH 4.8. The plates were left overnight in the dark at room temperature, following which the absorbance was read at 570-nm using an ELISA plate reader. Three to six wells were treated with 1% SDS (final concentration) for 5 min prior to adding the MTT reagent, and the average absorbance values obtained from these wells served as blank and was subtracted from all other results. Data points represent the Mean7s.d. of seven replicates per time point from 2-4 independent experiments.
Western blot analysis of lysates from detached cells
Samples containing equal amounts of protein were subjected to 10 or 15% SDS-PAGE and transferred to nitrocellulose. Routinely, nitrocellulose membranes were blocked for 1 h with 10% (v/v) low-fat milk in phosphate-buffered saline containing 0.1% Tween 20. Blocking of membranes was performed with 2% (w/v) BSA in phosphate-buffered saline containing 0.1% Tween 20 when probed with anti-Erk1/2, anti-phospho-Erk1/2, anti-Akt, anti-phospho-Ser473/Thr308-Akt, and antiphospho-(Ser/Thr)-Akt-substrate antibodies. The blots were then washed extensively and incubated with the appropriate horseradish peroxidase-linked secondary antibodies. Protein bands were detected by enhanced chemiluminescence using a commercially available kit (Amersham-Pharmacia Biotech, Buckinghamshire, England) and quantified using densitometry that was performed with the Quantity One v.4.1 software (Bio-Rad).
Induction of p53 and p21
WAF1/Cip1 by adriamycin
Cells were seeded at a concentration of 1.5 Â 10 6. cells/60-mm dish, cultured for 24 h in normal growth medium and then treated with 0.4 mM adriamycin in medium containing 0.1% FCS for 8-24 h. The adherent cells were washed twice with PBS and then scraped with a rubber policeman in 0.25 ml of RIPA lysis buffer. Samples containing equal amounts of protein were subjected to 10% SDS-PAGE, transferred to nitrocellulose, and analysed by Western blotting as described above.
Luciferase reporter plasmids, transfections and promoter activity assay MCF-7 and MCF-7/Cav1 cells were transiently transfected with IGF-IR promoter/luciferase reporter constructs p(À2350/ þ 640)LUC ('full-length' IGF-IR promoter) and p(À476/ þ 640)LUC ('proximal' IGF-IR promoter). Nucleotide þ 1 corresponds to the transcription start site of the rat IGF-IR gene. The basal promoter activities of these constructs have been previously described (Werner et al., 1994) . For control purposes, cells were transfected with the empty luciferase vector (p(0)LUC). Cells were seeded in six-well plates the day before transfection and transfected with 1 mg of the indicated reporter vector, along with 0.2 mg of a b-galactosidase expression plasmid (pCMVb; Clontech, Palo Alto, CA, USA) using jetPEIt transfection reagent (Polyplus Transfection, Illkirch, France). Following transfection, cells were incubated for 48 h at 371C, after which cells were collected and luciferase and bgalactosidase activities were measured as previously described (Werner et al., 1994) . Promoter activities were expressed as luciferase values normalized for b-galactosidase activity.
Activation of Erk1/2 and of Akt by IGF-I
Cells were seeded at a concentration of 1.5 Â 10 6. cells/60-mm dish, cultured for 24 h and then serum-starved for 24 h in RPMI medium supplemented with 0.1% fatty acid-free BSA. The activation of IGF-I receptor was carried out by incubating the cells for the indicated time with 50 ng/ml human IGF-I. The cells were washed twice with PBS and then scraped with a rubber policeman in 0.25 ml of RIPA lysis buffer. Samples containing equal amounts of protein were subjected to 10% SDS-PAGE, transferred to nitrocellulose, and analysed by Western blotting as described above.
Abbreviations ECM, extracellular matrix; IGF-I, insulin-like growth factor-I; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; PI3K, phosphoinositide 3-kinase; poly-HEMA, polyhydroxyethylmethacrylate.
